|1.||Jin, Yong: 1 article (08/2015)|
|2.||Cheng, Long: 1 article (08/2015)|
|3.||Chen, Yuan-Zheng: 1 article (08/2015)|
|4.||Yi, Nan: 1 article (08/2015)|
|5.||Gu, Xin-Shi: 1 article (08/2015)|
|6.||Peng, Yi: 1 article (08/2015)|
|7.||Bai, Xu-Ming: 1 article (08/2015)|
|8.||Cao, Wei-Jie: 1 article (10/2014)|
|9.||Zhang, Cheng: 1 article (10/2014)|
|10.||Wan, Ding-Ming: 1 article (10/2014)|
|1.||Chronic Hepatitis B
|2.||Lung Neoplasms (Lung Cancer)
09/26/2014 - "The results of this study suggest that cinobufotalin might be further investigated as a novel anti-lung cancer agent. "
09/26/2014 - "In the current study, we explored the potential anti-lung cancer activity of cinobufotalin in vivo and in vitro, and studied the underlying mechanisms. "
09/26/2014 - "Thus, cinobufotalin mainly induces Cyp-D-dependent non-apoptotic death in cultured lung cancer cells. "
09/26/2014 - "Pre-clinical evaluation of cinobufotalin as a potential anti-lung cancer agent."
09/26/2014 - "Using a mice xenograft model, we found that cinobufotalin inhibited A549 lung cancer cell growth in vivo. "
10/01/2014 - "The cinobufotalin is an effective reversal agent for the multidrug resistance of tumors. "
02/01/2008 - "TCM therapy applied in the 34 patients assigned in the TCM group (Group I ) included intravenous injection of Cinobufotalin, beta-elemene, or orally taking of anti-cancer Chinese herbs. "
02/20/2008 - "Treatment was more efficient in inhibiting the growth of transplanted tumors in H(22) mice when using the QHF formula (55.91%) than using Cinobufotalin (33.25%), Ginsenosides Rg3 (35.11%), PNS (27.12%) or Lentinan (4.97%) separately. "
02/20/2008 - "The optimal QHF dose ratio for anti-hepatic cell cancer treatment was: 800 mg/kg Cinobufotalin, 14 mg/kg Ginsenosides Rg3, 5.5 mg/kg PNS and 100 mg/kg Lentinan. "
03/01/2010 - "To investigate the synergistic anti-tumor effect of QHF (a Chinese medicine formula with anti-tumor active ingredients, including 800 mg/kg Cinobufotalin, 14 mg/kg Ginsenoside Rg3, 5.5 mg/kg Notoginseng and 100 mg/kg Lentinan) when combined with the chemotherapy drug cisplatin (DDP). "
|4.||Endometrial Neoplasms (Endometrial Cancer)
11/01/2010 - "[Effect of cinobufotalin on growth of xenograft of endometrial carcinoma cell line ishikawa in nude mouse and its impact on RRM2 expression]."
11/01/2010 - "To investigate the inhibitory effect of cinobufotalin (CBT) on the growth of xenograft endometrial carcinoma cell line ishikawa in nude mice, and its impact on the expression of ribonucleotide reductase subunit M2 (RRM2). "
|5.||Liver Neoplasms (Liver Cancer)
|3.||Mitochondrial Proteins (Mitochondrial Protein)
|4.||1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)
|5.||Ribonucleotide Reductases (Ribonucleotide Reductase)
|8.||mitochondrial permeability transition pore
|1.||Heterologous Transplantation (Xenotransplantation)
|3.||Drug Therapy (Chemotherapy)